{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:29:03Z","timestamp":1793410143019,"version":"4.5.0"},"reference-count":14,"publisher":"Knowledge E DMCC","issue":"4","content-domain":{"domain":["knepublishing.com"],"crossmark-restriction":true},"short-container-title":["JOVR"],"abstract":"<jats:p>Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IRPilo) in comparison with its original brand-name drug (Vuity). Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients received either IR-Pilo (n = 45) or Vuity (n = 30) and their contralateral eyes served as controls. Refractive errors, distance best-corrected visual acuity (BCVA), near vision, amplitude of accommodation, pupil size, and intraocular pressure (IOP) were measured before and 1 to 2 hours after instillation of the eye drop. Results: The mean refractive error was stable, except for a small myopic shift in the Vuity group. There was no significant change in distance BCVA. Near vision improved significantly in both intervention groups (P &lt; 0.001) with preference for IR-Pilo (4 vs 2.3). Furthermore, a higher amplitude of accommodation and pupil constriction occurred after instillation of both drops, with a higher effect associated with IR-Pilo. However, IOP did not change significantly post intervention. Conclusion: IR-Pilo and Vuity eye drops had comparable results; both were effective and led to stable distance vision and improved near vision. Both ophthalmic drugs were safe and none of them were associated with significant adverse effects.<\/jats:p>","DOI":"10.18502\/jovr.v19i4.14578","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T11:28:54Z","timestamp":1735644534000},"page":"468-475","update-policy":"https:\/\/doi.org\/10.18502\/knecrossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops"],"prefix":"10.18502","volume":"19","author":[{"given":"Seyed Abolghasem","family":"Mousavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4094-1062","authenticated-orcid":false,"given":"Zhale","family":"Rajavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Sabbaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-2952","authenticated-orcid":false,"given":"Saeid","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafeeseh","family":"Montazerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-8104","authenticated-orcid":false,"given":"Bahareh","family":"Kheiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Haseli- Monfared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7561-3467","authenticated-orcid":false,"given":"Kourosh","family":"Sheibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemn Baghban","family":"Jaldian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7770","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"235505","doi-asserted-by":"crossref","unstructured":"Wolffsohn JS, Davies LN. Presbyopia: Effectiveness of correction strategies. Prog Retin Eye Res 2019;68:124\u2013143.","DOI":"10.1016\/j.preteyeres.2018.09.004"},{"key":"235506","doi-asserted-by":"crossref","unstructured":"Katz JA, Karpecki PM, Dorca A, Chiva-Razavi S, Floyd H, Barnes E, et al. Presbyopia - A review of current treatment options and emerging therapies. Clin Ophthalmol 2021;15:2167\u20132178.","DOI":"10.2147\/OPTH.S259011"},{"key":"235507","unstructured":"Callina T, Reynolds TP. Traditional methods for the treatment of presbyopia: Spectacles, contact lenses, bifocal contact lenses [v.]. Ophthalmol Clin North Am 2006;19:25\u201333."},{"key":"235508","doi-asserted-by":"crossref","unstructured":"Grzybowski A, Markeviciute A, Zemaitiene R. A review of pharmacological presbyopia treatment. Asia Pac J Ophthalmol (Phila) 2020;9:226\u2013233.","DOI":"10.1097\/APO.0000000000000297"},{"key":"235509","doi-asserted-by":"crossref","unstructured":"Karanfil F\u00c7, Turgut B. Update on presbyopia-correcting drops. Eur Ophthalmic Rev 2017;11:99\u2013102.","DOI":"10.17925\/EOR.2017.11.02.99"},{"key":"235510","doi-asserted-by":"crossref","unstructured":"Mont\u00e9s-Mic\u00f3 R, Charman WN. Pharmacological strategies for presbyopia correction. J Refract Surg 2019;35:803\u2013814.","DOI":"10.3928\/1081597X-20191010-04"},{"key":"235511","doi-asserted-by":"crossref","unstructured":"Orman B, Benozzi G. Overview of pharmacological treatments for presbyopia. Med Hypothesis Discov Innov Optom 2020;1:67\u201377.","DOI":"10.51329\/mehdioptometry110"},{"key":"235512","unstructured":"Vuity - Pilocarpine ophthalmic solution for presbyopia. Med Lett Drugs Ther 2022;64:17\u201318."},{"key":"235513","unstructured":"Tucker T, Early J. Pilocarpine 1.25% ophthalmic solution (vuity) for the treatment of presbyopia. Am Fam Physician 2023;107:659\u2013660."},{"key":"235514","unstructured":"Benozzi G, Perez C, Leiro J, Facal S, Orman B. Presbyopia treatment with eye drops: An eight year retrospective study. Transl Vis Sci Technol 2020;9:25."},{"key":"235515","doi-asserted-by":"crossref","unstructured":"Galeana CAS. Cesar A Sanchez Galeana. Pharmacologic compound to mitigate presbyopia symptoms. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-980227\/v1","DOI":"10.21203\/rs.3.rs-980227\/v1"},{"key":"235516","doi-asserted-by":"crossref","unstructured":"Benozzi G, Cortina ME, Gimeno E, Vantesone DL, Solas AE, Lorda GM, et al. A multicentric study of pharmacological treatment for presbyopia. Graefes Arch Clin Exp Ophthalmol 2021;259:2441\u20132450.","DOI":"10.1007\/s00417-021-05138-8"},{"key":"235517","doi-asserted-by":"crossref","unstructured":"Vargas V, Vejarano F, Ali\u00f3 J. Pharmacological therapy for presbyopia in patients with previous corneal refractive surgery: A pilot study. Ophthalmol Ther 2020;9:1003\u20131010.","DOI":"10.1007\/s40123-020-00301-6"},{"key":"235518","doi-asserted-by":"crossref","unstructured":"Price FW Jr, Hom M, Moshirfar M, Evans D, Liu H, Penzner J, et al. Combinations of pilocarpine and oxymetazoline for the pharmacological treatment of presbyopia: Two randomized phase 2 studies. Ophthalmol Sci 2021;1:100065.","DOI":"10.1016\/j.xops.2021.100065"}],"container-title":["Journal of Ophthalmic and Vision Research"],"original-title":[],"link":[{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/download\/14578\/27863","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/download\/14578\/28045","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/download\/14578\/27863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T10:20:49Z","timestamp":1742552449000},"score":1,"resource":{"primary":{"URL":"https:\/\/knepublishing.com\/index.php\/JOVR\/article\/view\/14578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,31]]}},"URL":"https:\/\/doi.org\/10.18502\/jovr.v19i4.14578","relation":{},"ISSN":["2008-322X","2008-2010"],"issn-type":[{"value":"2008-322X","type":"electronic"},{"value":"2008-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}